iwNHL 2016: Highlights from Day 1
Catherine Bollard et al.
Understanding the complexity of acute myeloid leukemia (AML)
Ibrutinib updates from ASH 2016
How the treatment of AML will change
Mary Frances McMullin
Progress in acute myeloid leukemia treatment – collaborating to develop targeted therapies